We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Patient Features on Opioid Induced End-Tidal CO2 (Capno)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01371903
Recruitment Status : Completed
First Posted : June 13, 2011
Last Update Posted : March 24, 2014
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.

Condition or disease
Opioid Use During Medical Care

Detailed Description:
Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

Study Design

Study Type : Observational
Actual Enrollment : 278 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Patient Features on Opioid Induced End-Tidal CO2
Study Start Date : August 2010
Primary Completion Date : November 2012
Study Completion Date : November 2012
Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. end tidal carbon dioxide [ Time Frame: study start, 30 minutes, 60 minutes, 90 minutes, 120 minutes ]
    measured through small nasal cannula (plastic tube at base of nares)


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients receiving opioid such as morphine, fentanyl, or dilaudid during their emergency department visit.
Criteria

Inclusion Criteria:

  • non intubated patients receiving intravenous opioid medications

Exclusion Criteria:

  • mechanically ventilated patients
  • patients with physiologic shock
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01371903


Locations
United States, New York
Albany Medical Center Emergency Department
Albany, New York, United States, 12208
Sponsors and Collaborators
Albany Medical College
More Information

Responsible Party: Wayne Triner, Professor Emergency Medicine, Albany Medical College
ClinicalTrials.gov Identifier: NCT01371903     History of Changes
Other Study ID Numbers: 2792
First Posted: June 13, 2011    Key Record Dates
Last Update Posted: March 24, 2014
Last Verified: June 2011

Keywords provided by Wayne Triner, Albany Medical College:
morphine
fentanyl
dilaudid
opioid
capnography

Additional relevant MeSH terms:
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents